dc.contributor.author | Hendawy, O. M. | |
dc.contributor.author | Gomaa, Hesham A.M. | |
dc.contributor.author | Alzarea, Sami I. | |
dc.contributor.author | Alshammari, Mutariah S. | |
dc.contributor.author | Mohamed, Fatma A.M. | |
dc.contributor.author | Mostafa, Yaser A. | |
dc.contributor.author | Abdelazeem, Ahmed H. | |
dc.contributor.author | Abdelrahman, Mostafa H. | |
dc.contributor.author | Trembleau, Laurent | |
dc.contributor.author | Youssif, Bahaa G.M. | |
dc.date.accessioned | 2022-08-23T23:07:22Z | |
dc.date.available | 2022-08-23T23:07:22Z | |
dc.date.issued | 2021-11-01 | |
dc.identifier.citation | Hendawy , O M , Gomaa , H A M , Alzarea , S I , Alshammari , M S , Mohamed , F A M , Mostafa , Y A , Abdelazeem , A H , Abdelrahman , M H , Trembleau , L & Youssif , B G M 2021 , ' Novel 1,5-diaryl pyrazole-3-carboxamides as selective COX-2/sEH inhibitors with analgesic, anti-inflammatory, and lower cardiotoxicity effects ' , Bioorganic Chemistry , vol. 116 , 105302 . https://doi.org/10.1016/j.bioorg.2021.105302 | en |
dc.identifier.issn | 0045-2068 | |
dc.identifier.other | PURE: 200868606 | |
dc.identifier.other | PURE UUID: 7d1c98a9-938b-46c0-8aa9-d6a2141d72f1 | |
dc.identifier.other | Scopus: 85113795824 | |
dc.identifier.other | ORCID: /0000-0001-6376-9077/work/100717603 | |
dc.identifier.uri | https://hdl.handle.net/2164/19093 | |
dc.description | Funding Information: The authors extend their appreciation to the Deanship of Scientific Research at Jouf University for funding this work through research grant number (DSR2020-04-421 ) | en |
dc.format.extent | 14 | |
dc.language.iso | eng | |
dc.relation.ispartof | Bioorganic Chemistry | en |
dc.rights | this manuscript is available under CC BY NC ND licence.https://creativecommons.org/licenses/by-nc-nd/4.0/ | en |
dc.subject | Cardiomyopathy | en |
dc.subject | COX-2/sEH | en |
dc.subject | NSAIDS | en |
dc.subject | Pyrazoles | en |
dc.subject | QD Chemistry | en |
dc.subject | Biochemistry | en |
dc.subject | Molecular Biology | en |
dc.subject | Drug Discovery | en |
dc.subject | Organic Chemistry | en |
dc.subject | Supplementary Data | en |
dc.subject | https://doi. org/10.1016/j.bioorg.2021.105302 | en |
dc.subject.lcc | QD | en |
dc.title | Novel 1,5-diaryl pyrazole-3-carboxamides as selective COX-2/sEH inhibitors with analgesic, anti-inflammatory, and lower cardiotoxicity effects | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Chemistry | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1016/j.bioorg.2021.105302 | |
dc.date.embargoedUntil | 2022-08-24 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85113795824&partnerID=8YFLogxK | en |
dc.identifier.vol | 116 | en |